Evan Lippman

Evan Lippman

Executive Vice President, Business DevelopmentatTeva Pharmaceutical Industries· In the 2025 proxy

Pay in FY2025

Evan Lippman was paid $7.2M in FY2025 (Dec).

PayNo stock prices for these years
Pay is from the Summary Compensation Table of each Teva Pharmaceutical Industries proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Teva Pharmaceutical IndustriesPublic company · 1 yr
    • Executive Vice President, Business Development2025 – Present · 1 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?